The role of angiotensin II and of its receptor subtypes in the acetic acid-induced abdominal constriction test

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 2, 1999, Pages 229-232

  Georgieva, Daniela ^a   Georgiev, Vasil ^a  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Abdominal constrictions; Acetic acid; AT2 receptor subtype; Losartan; Mice; PD123319; Saralasin; Sarmesin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ACETIC ACID; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; LOSARTAN POTASSIUM; RECEPTOR SUBTYPE; SARALASIN; SARMESIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTESTINE CONTRACTION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL;

ACETIC ACID; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; COLIC; IMIDAZOLES; LOSARTAN; MALE; MICE; MICE, INBRED ICR; PAIN; PAIN MEASUREMENT; PYRIDINES; RECEPTORS, ANGIOTENSIN; SARALASIN;

EID: 0032910365     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00116-6     Document Type: Article

References (14)

1. Barnes N.M., Costall B., Kelly M.E., Murphy D.A., Naylor R.J. Anxiolitic-like action of DuP753, a nonpeptide angiotensin II receptor antagonist. Neuroreport. 1:1990;20-21.
2. Chernov H.I., Wilson D.E., Fowler F., Plummer A.J. Non-specificity of the mouse writhing test. Arch. Int. Pharmacodyn. Ther. 167:1967;171-178.
3. Collier H.O.J., Dinneen L.C., Johanson C.A., Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol. Chemother. 32:1968;295-310.
4. Georgiev V., Getova D., Opitz M. Mechanisms of the angiotensin II effects on the exploratory behavior of rats in open field. I. Interaction of angiotensin II with saralasin and catecholaminergic drugs. Methods Find. Exp. Clin. Pharmacol. 9:1987;297-301.
5. Georgiev V. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II. Pol. J. Pharmacol. Pharm. 42:1990;553-562.
6. Georgiev V.P., Lazarova M.B., Kambourova T.S. Further evidence for the interactions between angiotensin II and GABAergic transmission in pentylenetetrazol kindling seizures in mice. Neuropeptides. 28:1995;29-34.
7. Georgiev V., Matsoukas J.M., Georgieva D., Tchekalarova J., Todorov I. Influence of sarmesin on some dopamine-related types of behaviour. Lett. Peptide Sci. (LIPS). 3:1996;185-190.
8. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injections of dugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
9. Haulica I., Neamtu C., Stratone A., Petrescu G., Branisteanu D., Rosca V., Slatineanu S. Evidence for the involvement of cerebral renin-angiotensin system (RAS) in stress analgesia. Pain. 27:1986;237-245.
10. Hayes A.G., Sheehan M.J., Tyers M.B. Differential sensitivity of models of antinociception in the rat, mouse and guinea pig to μ- and κ-opioid receptor agonists. Br. J. Pharmacol. 91:1987;823-832.
11. Kaneko S., Mori A., Tamura S., Satoh M., Takagi H. Intracerebroventricular administration of angiotensin II attenuates morphine-induced analgesia in mice. Neuropharmacology. 24:1985;1131-1134.
12. Timmermans P.B.W.M., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., Lee R.J., Wexler R.R., Saye A.M., Smith R.D. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45:1993;205-251.
13. Tsuda A., Tanaka M., Georgiev V., Emoto H. Effects of angiotensin II on behavioral responses of defensive burying paradigm in rats. Pharmacol. Biochem. Behav. 43:1992;729-732.
14. 4 and their functions. Regul. Pept. 59:1995;269-295.